Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Korea.
Mol Cells. 2021 May 31;44(5):328-334. doi: 10.14348/molcells.2021.0052.
The advent of the major histocompatibility complex (MHC) multimer technology has led to a breakthrough in the quantification and analysis of antigen-specific T cells. In particular, this technology has dramatically advanced the measurement and analysis of CD8 T cells and is being applied more widely. In addition, the scope of application of MHC multimer technology is gradually expanding to other T cells such as CD4 T cells, natural killer T cells, and mucosal-associated invariant T cells. MHC multimer technology acts by complementing the T-cell receptor-MHC/peptide complex affinity, which is relatively low compared to antigen-antibody affinity, through a multivalent interaction. The application of MHC multimer technology has expanded to include various functions such as quantification and analysis of antigen-specific T cells, cell sorting, depletion, stimulation to replace antigen-presenting cells, and single-cell classification through DNA barcodes. This review aims to provide the latest knowledge of MHC multimer technology, which is constantly evolving, broaden understanding of this technology, and promote its widespread use.
主要组织相容性复合体 (MHC) 多聚体技术的出现,使得抗原特异性 T 细胞的定量和分析有了突破。特别是这项技术极大地推动了 CD8 T 细胞的测量和分析,并且应用越来越广泛。此外,MHC 多聚体技术的应用范围逐渐扩展到其他 T 细胞,如 CD4 T 细胞、自然杀伤 T 细胞和黏膜相关不变 T 细胞。MHC 多聚体技术通过多价相互作用,补充了 T 细胞受体-MHC/肽复合物的亲和力,与抗原-抗体亲和力相比,这种亲和力相对较低。MHC 多聚体技术的应用已经扩展到包括定量和分析抗原特异性 T 细胞、细胞分选、耗竭、刺激以替代抗原呈递细胞以及通过 DNA 条形码进行单细胞分类等各种功能。本综述旨在提供不断发展的 MHC 多聚体技术的最新知识,拓宽对该技术的理解,并促进其广泛应用。